A Study of the Pharmacokinetics of Three Dosages of Niagen in Healthy Subjects

Sponsor: KGK Science Inc.
Collaborator: ChromaDex, Inc.

Purpose

To analyze the way in which the body processes Niagen in healthy people. Blood and urine samples from subjects who are given a dose of Niagen will be analyzed for metabolites over the 24 hours after taking the dose.

Study Design

Double blind, single dose, three-arm, controlled cross-over

Dose

100mg/day, 300mg/day, or 1000mg/day

Length of Intervention

Single dose

Status

Completed

Condition or Disease 

Pharmacokinetics

Timeline estimations sourced on clinicaltrials.gov. All timing subject to change.

Clinical Studies, Pharmacokinetic/Safety, CompletedANAD Staff